logo

For the Inventor, By the Inventor

Tokyo, Japan

Anaeropharma Science, Inc.


USPTO Granted Patents = 13

% Expired Patents = 38.5



Forward Citations = 50

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Takayuki Sasaki (7 out of 107 patents)

silverMedal Yuko Shimatani-Shibata (5 out of 5 patents)

bronzeMedal Minoru Fujimori (5 out of 5 patents)

4.  Shun'ichiro Taniguchi (5 out of 5 patents)

5.  Yuko Shimatani (4 out of 4 patents)

6.  Hitomi Shimizu (4 out of 5 patents)

7.  Jun Amano (4 out of 7 patents)

8.  Takeshi Masaki (3 out of 4 patents)

9.  Hitomi Shimizu-Matsuhashi (3 out of 3 patents)

10.  Yoshinori Hamaji (3 out of 3 patents)

11.  Hiromi Yonekura (3 out of 3 patents)

12.  Yuko Wada (2 out of 2 patents)

13.  Koichi Koseki (2 out of 2 patents)

14.  Koichiro Shioya (2 out of 2 patents)

15.  Satoshi Kobayashi (2 out of 19 patents)


13 patents:

1. 10993972 - Therapeutic agent for ischemic diseases (2021-05-04),
2. 10563208 - Co-expression plasmid (2020-02-18),
3. 10443061 - Heterologous polypeptide expression cassette (2019-10-15),
4. 9730968 - Therapeutic agent for ischemic diseases (2017-08-15),
5. 9228191 - Transfection vector (2016-01-05),
6. 8911721 - Method of constructing gene transport support (2014-12-16),
7. 8734779 - 5-fluorouracil-resistant bacteria and method for production thereof (2014-05-27),
8. 8535939 - Transfection vector (2013-09-17),
9. 8470311 - Therapeutic agent for anaerobic diseases (2013-06-25),
10. 8383398 - Expression vector (2013-02-26),
11. 8338162 - Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium (2012-12-25),
12. 8021653 - [object Object] (2011-09-20),
13. 7740835 - Anaerobic bacterium as a drug for cancer gene therapy (2010-06-22),
Company Overview
Anaeropharma Science, Inc. is a biotechnology company based in Tokyo, Japan, specializing in the development of innovative therapeutics derived from anaerobic microorganisms. The organization focuses on harnessing the unique properties of these microorganisms to create novel treatments for various diseases, particularly in the fields of oncology and infectious diseases. By leveraging advanced research methodologies and cutting-edge technology, Anaeropharma aims to address unmet medical needs and contribute to the advancement of healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#1,660 in Tokyo

#3,749 in Japan

#45,039 in the World

Tokyo, JP
Tokyo, Japan

Anaeropharma Science, Inc.

Forward Citations = 50

28 inventors:

goldMedal Takayuki Sasaki (7 out of 107 patents)

silverMedal Yuko Shimatani-Shibata (5 out of 5 patents)

bronzeMedal Minoru Fujimori (5 out of 5 patents)

4.  Shun'ichiro Taniguchi (5 out of 5 patents)

5.  Yuko Shimatani (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Anaeropharma Science, Inc.. Retrieved from https://idiyas.com/company/anaeropharma-science

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…